Because of economic constraints and the lack of gene-tandem mass spectrometry 5 or 6 years ago, many children died from unexplained encephalopathy in the neonatal period, leaving CTLN1 undiagnosed and providing a small sample size for this study. This evidence concerns the gene ASS1 and Encephalopathy.